Furqan, M.; Elliott, R.J.R.; Nagle, P.W.K.; Dawson, J.C.; Masalmeh, R.; Garcia, V.A.; Munro, A.F.; Drake, C.; Morrison, G.M.; Pollard, S.M.;
et al. Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics 2025, 17, 549.
https://doi.org/10.3390/pharmaceutics17050549
AMA Style
Furqan M, Elliott RJR, Nagle PWK, Dawson JC, Masalmeh R, Garcia VA, Munro AF, Drake C, Morrison GM, Pollard SM,
et al. Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics. 2025; 17(5):549.
https://doi.org/10.3390/pharmaceutics17050549
Chicago/Turabian Style
Furqan, Muhammad, Richard J. R. Elliott, Peter W. K. Nagle, John C. Dawson, Roza Masalmeh, Virginia Alvarez Garcia, Alison F. Munro, Camilla Drake, Gillian M. Morrison, Steven M. Pollard,
and et al. 2025. "Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma" Pharmaceutics 17, no. 5: 549.
https://doi.org/10.3390/pharmaceutics17050549
APA Style
Furqan, M., Elliott, R. J. R., Nagle, P. W. K., Dawson, J. C., Masalmeh, R., Garcia, V. A., Munro, A. F., Drake, C., Morrison, G. M., Pollard, S. M., Ebner, D., Brunton, V. G., Frame, M. C., & Carragher, N. O.
(2025). Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics, 17(5), 549.
https://doi.org/10.3390/pharmaceutics17050549
